Biosensors, Plasmonic Assemblies, and Global Market Insights
- mhauser994
- Apr 30, 2024
- 2 min read
As published in the SV April 2024 Newsletter
Biosensors are transforming healthcare and research for the better. They aid in detecting and monitoring diseases cost-effectively, enabling researchers and healthcare providers to address challenges such as food safety and human biology. They play a vital role in medical instruments, facilitating accurate identification of biomarkers and prompt treatment.
Global market insights
The biosensors market is growing rapidly, driven by increasing use in healthcare and other industries. Estimated to be worth USD 25.5 billion in 2021, it is projected to reach USD 36.7 billion by 2026, and USD 48.89 billion by 2030. The global biosensors market is highly competitive, and biosensors find applications in medical diagnosis, food safety, environmental monitoring, and biodefense.
Biosensing: A new era in research sciences and healthcare
Biosensors are analytical devices that turn biological responses into electrical signals. These devices are crucial for detecting and measuring substances in fields like healthcare and environmental monitoring. They are designed to be highly specific, targeting the desired substance in complex samples. They speed up experiments, like drug discovery, by providing real-time data and faster decision-making. In healthcare, biosensors are transforming patient monitoring and disease diagnosis, as in continuous glucose monitoring for diabetes. They're also crucial for quickly detecting infectious diseases like COVID-19, helping with early detection and disease control.
Plasmonic Assemblies for Real-Time Single-Molecule Biosensing
Plasmonic nanoparticles are incredibly useful in many applications. By arranging them in different configurations, we can make new materials with different optical properties, useful for biosensing and color printing.
In biosensing, these tiny particles can detect even the smallest amounts of biomarkers, like proteins or DNA, under a microscope. They're highly sensitive, able to detect changes caused by samples containing only one molecule of a given substance. This can help scientists understand chemical and biological functions and how they interact. Scientists are also using these nanoparticles to track how molecules move and change in real-time, shedding new light on how diseases start or how drugs work in the body.
Nanocrine is deeply invested in applying nanotechnology to biosensing. Leveraging patented technology licensed from the US Naval Research Laboratory, Nanocrine's proprietary Plasmonic Imaging Chip (PIC) enables innovative cell phenotyping capabilities crucial for disease and infection analysis. Anticipated outcomes include advancements in therapeutic development, mitigating cancer metastasis, and reducing neurological decline in neurodegenerative conditions. Their endeavors hold promise for significant future achievements.
IUPAC. Compendium of Chemical Terminology - the Gold Book. Biosensor. 1997. Wang, J. Electrochemical biosensors: towards point-of-care cancer diagnostics
Biosens. Bioelectron., 21 (10) (2006), pp. 1887-1892
Comments